Commentary

Prostate cancer screening and the role of PSA: A UK perspective

Prasanna Sooriakumaran, MD, PhD, FRCSUrol, FEBU
Cleveland Clinic Journal of Medicine January 2021, 88 (1) 14-16; DOI: https://doi.org/10.3949/ccjm.88a.20164

Article Information

vol. 88 no. 1 14-16
DOI 
https://doi.org/10.3949/ccjm.88a.20164
PubMed 
33384307
Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online December 31, 2020.
Copyright & Usage 
Copyright © 2021 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Prasanna Sooriakumaran, MD, PhD, FRCSUrol, FEBU⇑
  1. Lead for Urology, Urology Service, Digestive Diseases & Surgery Institute, Cleveland Clinic London, UK
  1. Address:
    Prasanna Sooriakumaran, MD, PhD, FRCSUrol, FEBU, Digestive Diseases and Surgery Institute, Cleveland Clinic London, 33 Grosvenor Pl, Belgravia, London SW1X 7HY, United Kingdom; psoori{at}santishealth.org
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Subjects